CASI Pharmaceuticals, Inc.
Pharmaceutical company · Beijing, China · OTC: CASIF
CASI Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Beijing, China. Its earliest recorded incorporation is in 2023. Its shares trade on OTC under the ticker CASIF. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2026.
CASI Pharmaceuticals at a glance
What does CASI Pharmaceuticals do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $5 million sold (2026).
Frequently asked questions about CASI Pharmaceuticals
Where is CASI Pharmaceuticals headquartered?
CASI Pharmaceuticals, Inc. is headquartered in Beijing, China.
What does CASI Pharmaceuticals do?
CASI Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is CASI Pharmaceuticals a public company?
Yes. CASI Pharmaceuticals, Inc. trades on OTC under the ticker CASIF.
When was CASI Pharmaceuticals founded?
The earliest incorporation on record for CASI Pharmaceuticals, Inc. is in 2023, according to public company registers.
Similar companies
- Xynomic Pharmaceuticals Holdings, Inc.Beijing, China
- Sinovac Biotech LtdBeijing, China
- Zai Lab LtdShanghai, China
- Qilu Pharmaceutical Co., Ltd.Jinan, Shandong, China
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.Lianyungang, Jiangsu, China
- Bohai Pharmaceuticals Group, Inc.Yantai, Shandong, China
- Hangzhou Zhongmei Huadong Pharmaceutical Co., LtdHangzhou, Zhejiang, China
- HUTCHMED LimitedSuzhou, Jiangsu, China
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences